Healthcare Industry News 10 October 2025

Moderna (MRNA) Sets 3‑Year mRNA Growth Plan After $1.5 Billion Loan and $140 Million U.S. Expansion – November 20, 2025

Moderna (MRNA) secured a $1.5 billion Ares loan, outlined a three‑year strategy targeting up to 10% revenue growth in 2026, and confirmed a $140 million U.S. manufacturing expansion as it races toward cash breakeven by 2028. Moderna’s pivotal day: liquidity

20 November 2025

Biotechnology·Business News·Healthcare Industry·Investment·Pharmaceuticals

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

UnitedHealth Group’s UNH stock has become one of the most controversial names in the Dow in 2025. After a brutal sell-off driven by a massive cyberattack, rising medical costs and intensifying federal investigations, the stock is trying to stage a

15 November 2025

Financial Forecasts·Healthcare Industry·Investment Analysis·Stock Market

Pfizer Completes $10 Billion Metsera (MTSR) Buyout as Nasdaq Delists Stock Today

Metsera Inc. (NASDAQ: MTSR) stops trading today, November 14, 2025, as Pfizer closes its up to $10 billion obesity-drug acquisition. Here’s what Metsera shareholders and obesity-market investors need to know about the deal terms, CVR, delisting, and future milestones. Date:

14 November 2025

Business Updates·Healthcare Industry·Mergers & Acquisitions·Pharmaceuticals·Stock Market News

Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play

In-Depth Analysis BMS’s acquisition of Orbital Therapeutics marks a deliberate push into autoimmune disease treatment via advanced cell therapy. Orbital, founded in 2022 by leaders in RNA and immunology, has built a proprietary RNA platform combining circular and linear RNA

10 October 2025

Biotech·Healthcare Industry·Investment·Mergers & Acquisitions·Pharma News

Healthcare Industry News 10 October 2025 - 20 November 2025

Moderna (MRNA) Sets 3‑Year mRNA Growth Plan After $1.5 Billion Loan and $140 Million U.S. Expansion – November 20, 2025

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

Pfizer Completes $10 Billion Metsera (MTSR) Buyout as Nasdaq Delists Stock Today

Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play